European Medicines Agency accepts AstraZeneca's marketing application for Lesinurad, a treatment for gout. "AstraZeneca's Lesinurad Gout Treatment Receives EMA Approval," at 0715 GMT, misstated in the first paragraph that the European Medicines Agency has approved rather than accepted its marketing application for Lesinurad. The second paragraph should also begin with "If approved" not "The authorization means".

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more AstraZeneca Charts.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more AstraZeneca Charts.